Impax Asset Management Group »

Alnylam Pharmaceuticals shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $495k 2.6k 191.41
2023-09-30 $514k 2.9k 177.10
2023-06-30 $583k 3.1k 189.94
2023-03-31 $605k 3.0k 200.32
2022-12-31 $644k 2.7k 237.65
2022-09-30 $733k 3.7k 200.16
2022-06-30 $483k 3.3k 145.83
2022-03-31 $669k 4.1k 163.25
2021-12-31 $642k 3.8k 169.35
2021-09-30 $3.1M 16k 188.82
2021-06-30 $2.8M 16k 169.52
2021-03-31 $2.3M 16k 141.21
2020-12-31 $2.1M 16k 129.97
2020-09-30 $7.4M 51k 145.60
2020-06-30 $4.5M 30k 148.11
2020-03-31 $2.3M 21k 108.87
2019-12-31 $283k 2.5k 115.09